ReachMD
Be part of the knowledge.™Public Profile
close
Affiliations
Vanderbilt University School of Medicine
DisclosuresDr. Roden receives royalties on a patent related to predicting drug-induced arrhythmias. He is currently a consultant to Merck, Novartis, Astellas, Sanofi, Dai-ichi Sankyo.
| Program Name | Last Air Date | Hosts/Guests |
|---|---|---|
| Genetic Testing for Long QT Syndrome | 11/14/2018 | |
| DNA Biobanks Empowering Personalized Medicine | 03/17/2016 | |
| Drug Response Variability: Toward Customized Treatments for Arrhythmias | 02/26/2016 |
Programs 2/28/20
